- Home
- BAM vs MDT Comparison
BAM vs MDT Comparison
Compare BAM & MDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BAM
- MDT
- Stock Information
- Founded
- BAM 2022
- MDT 1949
- Country
- BAM United States
- MDT Ireland
- Employees
- BAM N/A
- MDT N/A
- Industry
- BAM
- MDT Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- BAM
- MDT Health Care
- Exchange
- BAM Nasdaq
- MDT Nasdaq
- Market Cap
- BAM 99.5B
- MDT 114.9B
- IPO Year
- BAM N/A
- MDT N/A
- Fundamental
- Price
- BAM $59.03
- MDT $92.84
- Analyst Decision
- BAM Buy
- MDT Buy
- Analyst Count
- BAM 12
- MDT 15
- Target Price
- BAM $63.35
- MDT $102.62
- AVG Volume (30 Days)
- BAM 1.7M
- MDT 7.3M
- Earning Date
- BAM 11-03-2025
- MDT 08-19-2025
- Dividend Yield
- BAM 2.87%
- MDT 3.06%
- EPS Growth
- BAM 42.80
- MDT 21.95
- EPS
- BAM 1.49
- MDT 3.62
- Revenue
- BAM $4,351,000,000.00
- MDT $34,200,000,000.00
- Revenue This Year
- BAM $34.50
- MDT $7.58
- Revenue Next Year
- BAM $14.35
- MDT $5.40
- P/E Ratio
- BAM $39.57
- MDT $25.64
- Revenue Growth
- BAM 13.81
- MDT 4.98
- 52 Week Low
- BAM $39.19
- MDT $79.29
- 52 Week High
- BAM $64.10
- MDT $96.25
- Technical
- Relative Strength Index (RSI)
- BAM 43.96
- MDT 54.75
- Support Level
- BAM $59.58
- MDT $91.42
- Resistance Level
- BAM $61.29
- MDT $93.83
- Average True Range (ATR)
- BAM 1.13
- MDT 1.65
- MACD
- BAM -0.32
- MDT -0.04
- Stochastic Oscillator
- BAM 31.92
- MDT 76.95
About BAM Brookfield Asset Management Inc Limited Voting Shares
Brookfield Asset Management Ltd engages in providing alternative asset management services through an ownership interest in a alternative asset management business. It offers a range of alternative investment products to investors around the world including public and private pension plans, endowments and foundations, sovereign wealth funds, financial institutions, insurance companies, and private wealth investors.
About MDT Medtronic plc.
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.